Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 47 |
| Active Pipeline (Recruiting Now) | 23 (12) |
| Completed vs Stopped Early | 7 / 11 (23.4%) |
| Median Closed Actual Enrollment | 30 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| USC Norris Comprehensive Cancer Center and Keck Medicine | Los Angeles, CA | 39 |
| Los Angeles General Medical Center | Los Angeles, CA | 2 |
| City of Hope National Medical Center | Duarte, CA | 2 |
Explore interactive annual charts and M&A subsidiary rollups in the University of Southern California Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.